JPRN-UMIN000016879已完成未知
Mutation analyses of plasma and tumor DNA in EGFR mutation-positive advanced non-small-cell lung cancer. - Liquid Biopsy Study
Clinical Research Support Center Kyushu0 个研究点目标入组 100 人开始时间: 2015年3月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with positive HBs antigen or HVC antibody. 2) Patient with definite positive HIV antibody (need not for examination). 3) Any other patients who are regarded as unsuitable for this study by the investigators.
研究者
相似试验
招募中
不适用
EGFR-mutation analysis of circulating tumor DNA with high sensitive methods and concordance to effect of EGFR-TKI.non-small cell lung cancerJPRN-UMIN000016348Miyagi Cancer Center30
已完成
不适用
Monitoring study of genomic mutations in patients with EGFR mutation or ALK translocation using plasma DNAnon-small-cell lung cancerJPRN-UMIN000035628Wakayama Medical University100
已完成
不适用
Monitoring EGFR mutation status with cell-free DNA: a prospective exploratory analyses of phase Ib study of osimertinib plus ramucirumab in lung adenocarcinoma patients with EGFR T790M mutatioung CancerJPRN-UMIN000030164Wakayama Medical University3
招募中
不适用
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatmentnon-small cell lung cancerJPRN-UMIN000037232Advanced Cancer Translational Research Institute100
已完成
不适用
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60